CONMED (CNMD) PT Lowered to $40 at JPMorgan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $45.26 -1.09%
Rating Summary:
5 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 24 | New: 16
Rating Summary:
5 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 24 | New: 16
Join SI Premium – FREE
JPMorgan analyst Robbie Marcus lowered the price target on CONMED (NYSE: CNMD) to $40.00 (from $43.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Exlservice (EXLS) PT Raised to $48 at Stifel
- HSBC Upgrades FedEx (FDX) to Buy
- ServiceNow (NOW) PT Raised to $140 at Freedom Broker
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
